Apellis Pharmaceuticals Inc ROCE
Mi az Apellis Pharmaceuticals Inc ROCE?
A ROCE az Apellis Pharmaceuticals Inc - -40.79%
Mi a ROCE meghatározása?
A befektetett tőke megtérülése (ROCE) olyan pénzügyi arány, amely a vállalat jövedelmezőségét és a tőke felhasználásának hatékonyságát méri.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE a Health Care szektor a NASDAQ-on cégekben a Apellis Pharmaceuticals Inc -hoz képest
Mit csinál Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
roce -hoz hasonló cégek Apellis Pharmaceuticals Inc
- WISeKey International Ltd nak ROCE -41.00% van
- WISeKey International AG nak ROCE -41.00% van
- LiqTech International nak ROCE -40.94% van
- LiqTech International Inc nak ROCE -40.94% van
- NioCorp Developments nak ROCE -40.90% van
- Temas Resources nak ROCE -40.85% van
- Apellis Pharmaceuticals Inc nak ROCE -40.79% van
- Oak Street Health nak ROCE -40.74% van
- Adamas Pharmaceuticals Inc nak ROCE -40.72% van
- Silver Wolf Exploration nak ROCE -40.67% van
- Sherpa II nak ROCE -40.64% van
- The Mandhana Retail Ventures nak ROCE -40.63% van
- Aclaris Therapeutics Inc nak ROCE -40.61% van